Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Cigna GroupWBO:CIGN +0.46%73 3-Year EPS without NRI Growth Rate is 8.50% as of Jun. 2026, which is 21% below its 10-year median of 10.80. GuruFocus rates WBO:CIGN with a GF Score™ of 73/100 and a GF Value™ of €342.83 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 17 Healthcare Plans companies, The Cigna Group ranks better than 52.94% on this metric.
During the past 12 months, The Cigna Group's average EPS without NRI Growth Rate was 22.30% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 8.50% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 10.00% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 14.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of The Cigna Group was 237.60% per year. The lowest was -45.90% per year. And the median was 10.80% per year.
The Cigna Group (WBO:CIGN) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
The Cigna Group 3-Year EPS without NRI Growth Rate Related Terms
WBO:CIGN vs ELV, HUM, CNC: 3-Year EPS without NRI Growth Rate Comparison
For the Healthcare Plans subindustry, The Cigna Group's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cigna Group 3-Year EPS without NRI Growth Rate vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, The Cigna Group's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where The Cigna Group's 3-Year EPS without NRI Growth Rate falls into.
The Cigna Group 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 8.50% mean?
The Cigna Group (WBO:CIGN) has a 3-Year EPS without NRI Growth Rate of 8.50% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for The Cigna Group and its competitors. This is 21% below median its historical median of 10.80. According to the industry distribution chart, The Cigna Group ranks #8 out of 17 companies in the Healthcare Plans industry, placing it in the top 47.1%.
Is The Cigna Group's 3-Year EPS without NRI Growth Rate too high?
The Cigna Group's current 3-Year EPS without NRI Growth Rate of 8.50% is 21% below median its 10-year median of 10.80. The Healthcare Plans industry median 3-Year EPS without NRI Growth Rate is 1.40. The Cigna Group's value of 8.50% is 507.1% above this industry median. Based on the distribution chart, The Cigna Group ranks #8 out of 17 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, The Cigna Group has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cigna Group's 3-Year EPS without NRI Growth Rate compare to ELV and HUM?
According to the Healthcare Plans industry distribution chart, The Cigna Group ranks #8 out of 17 companies for 3-Year EPS without NRI Growth Rate. This puts The Cigna Group in the upper half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 1.40. The Cigna Group's value of 8.50% is 507.1% above this benchmark. While the company's 10-year median is 10.80 vs. the industry median of 1.40, The Cigna Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Healthcare Plans company?
The median 3-Year EPS without NRI Growth Rate among Healthcare Plans companies is 1.40, based on 17 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Cigna Group's current 3-Year EPS without NRI Growth Rate of 8.50% is 507.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for The Cigna Group and its competitors. For the Healthcare Plans industry, the median 3-Year EPS without NRI Growth Rate is 1.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Cigna Group's current 3-Year EPS without NRI Growth Rate is 8.50%, which is 21% below median its own 10-year median of 10.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cigna Group stock overvalued right now?
Based on GuruFocus' analysis, The Cigna Group (WBO:CIGN) is currently considered Modestly Undervalued. The stock's GF Value™ is €342.83, compared to a current price of €242.60 — trading 29.2% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 8.50%, which is 21% below median its 10-year median of 10.80 and 507.1% above the Healthcare Plans industry median of 1.40. The Cigna Group's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For The Cigna Group (WBO:CIGN), the current 3-Year EPS without NRI Growth Rate is 8.50% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Cigna Group (WBO:CIGN) Overvalued in 2026?
Based on GuruFocus' analysis, The Cigna Group stock appears to be undervalued.
The current stock price of €242.60 is trading 29.2% below its estimated GF Value™ of €342.83.
GuruFocus considers The Cigna Group to be Modestly Undervalued.
Key valuation signals for WBO:CIGN:
3-Year EPS without NRI Growth Rate: 8.50% (21% below median its 10-year median of 10.80)
GF Value™: €342.83 vs. price of €242.60 (29.2% below fair value)
Industry Position: 507.1% above the Healthcare Plans median (#8 of 17)
No single metric tells the full story. See the WBO:CIGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
73GF Score
Get the complete analysis for WBO:CIGN
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:CIGN has been successfully added to your 
